Other articles by Bob Christie:

Bashas' replaces tainted peppers Arrested again, rapper now faces drug, cruelty charges Illinois ex-priest faces molestation charges in Arizona Kin of woman who died in custody at Phoenix airport file $8M claim Napolitano to reject abstinence-only funds Former Pima County deputy in landmark court winPima County deputy wins Supreme Court suit against State FarmJudge rejects suit against Grand Canyon use plan Uncle coming to help boy rescued by entrant Agitated woman, held at Sky Harbor, dies in custody

Production and Manufacturing
QUALITY MANAGER Sales and Marketing
Town and Country Foods
Sales Manager Driver/Transportation
DRIVERS Driver/Transportation
REPOSSESSION DRIVERS Trades/Construction
SCHMUESER & ASSOCIATES
PRECSION MILLWRIGHTS Technical
Dynamics Information Technology
Systems Engineer Administrative & Professional
Pima Prevention Partnership
Administrative Assistant

PHOENIX — A Lake Havasu City couple who ran a company that allegedly imported Indian-made knockoffs of popular prescription drugs and sold them as brand-name U.S. drugs has been indicted by a federal grand jury, the U.S. Attorney's Office in Phoenix announced Wednesday.

Randy T. French, 52, and his wife, Sheila D. French, 42, face charges of conspiracy, smuggling, mail and wire fraud, and shipping misbranded drugs in interstate commerce. Their company, Prescription Buyer's Group Inc., was indicted on the same criminal counts.

According to the indictment, the couple's firm offered more than 600 name-brand drugs, including blockbusters such as Viagra, Celebrex and Lipitor, at deep discounts through its Web site and toll-free telephone lines. The government alleges the company instead sent knockoffs manufactured in India that weren't approved by the U.S. Food and Drug Administration and which they had smuggled into the United States.

Between July 2004 and January 2006, the company filled more than 15,000 orders and generated revenue of more than $2.5 million, according to the government.

The couple were issued a summons, but a court date hasn't been set. The phone listing for Randy French in Lake Havasu City didn't take messages, and the U.S. Attorney's Office did not know if the couple had a lawyer. A telephone listing for Prescription Buyer's Group rang unanswered.

The indictment also seeks forfeiture of assets the couple obtained through the alleged illegal activities.

According to the indictment, the Frenches incorporated Prescription Buyer's Group in Arizona in September 2002.

In July 2004 and again in September 2004, an undercover investigator with drug maker Eli Lilly and Co. placed orders for the company's impotence drug, Cialis, with Prescription Buyer's Group. Within a month, in each case the operative received a drug labeled as "Tadalis," according to the indictment.

Robert Reilley, Eli Lilly's director of global security, said Wednesday that Tadalis appears to be an unapproved generic. He said Eli Lilly uses employees with law-enforcement backgrounds to look for firms hawking fake or counterfeit drugs. They then turn any information they gather over to law enforcement for possible prosecution.

The problem is a big one, especially with Internet sales, in which buyers have no guarantee of what they're really getting, Reilley said. He said there are legitimate pharmacies on the Web, but they're small in number compared with those selling counterfeits or unapproved generics.

"Our recommendation to any patient is to buy through a known pharmacy, through their doctors, and not blindly through the Internet, where they might not know . . . what they're actually going to get at the end of the day," Reilley said. "They're relying solely on the appearance of a Web site, and what you see is not always what you get."

By late 2004, federal investigators began ordering name-brand drugs and receiving mail shipments of knockoffs from the Frenches' company, according to the indictment. They continued making buys until mid-2006.

A spokeswoman for the U.S. attorney in Phoenix said she couldn't confirm whether the company had been shut down.

The investigation was led by the FDA's criminal investigation's division. An FDA spokeswoman didn't respond to calls seeking comment.